Molecular Research in Gynecological Diseases—2nd Edition
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 20 August 2025 | Viewed by 3461
Special Issue Editor
Interests: nanoparticles; carcinogenic potential; lactoferrin; caner therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The Centers for Disease Control and Prevention recognizes five types of gynecologic cancers as follows: cervical cancer, ovarian cancer, uterine cancer, vaginal cancer, and vulvar cancer. GLOBOCAN 2020 reports that these cancers represent the fifth leading cause of cancer-related deaths. Notably, a screening test that can detect gynecological cancers in their early stages exists only for cervical cancer. Consequently, screening tests for these cancers are a high priority. This is especially true for ovarian cancers, which are associated with poor outcomes. The American Cancer Society estimates that, in 2023, in the United States, 19,710 women will be diagnosed with ovarian cancer, and 13,270 women will die from ovarian cancer.
It is well known that benign gynecological diseases affect a huge number of women. It is estimated that adenomyosis and leiomyomas (also known as uterine fibroids) each affect approximately 20% of women who are of a reproductive age, and that endometriosis and polycystic ovary syndrome (PCOS) each affect approximately 10% of women who are of a reproductive age. Other benign gynecological conditions also affect a significant percentage of women. However, benign gynecological diseases are oftentimes ignored. For example, in reference to endometriosis, the New York Times (27 April 2021) states “Yet, it suffers from a branding problem: It falls into the abyss of “women’s diseases” (overlooked), diseases that do not kill you (unimportant), and menstrual problems (taboo)”, and the Guardian (2 June 2022) states “Doctors’ routine dismissal of women’s debilitating health problems as “benign” has contributed to gynaecology waiting lists soaring by 60% to more than half a million patients, a senior health leader has said”. While benign gynecological diseases are generally not fatal, they have a significant adverse effect on the quality of life of millions of women.
The International Journal of Molecular Sciences introduces this Special Issue to create a collection of papers regarding specific topics and to build a community of authors and readers, enabling the discussion of the latest research and the developing of new ideas and research directions. This Special Issue is soliciting review articles, original research articles, and short communications regarding the molecular aspects of gynecological diseases. These include identifying markers that can be used in the screening and diagnosis of relevant gynecological diseases, investigating DNA mutations and cellular signaling pathways that lead to the development of the disease, investigating the involvement of the microbiota in various gynecological diseases, and identifying targets that can be used in the treatment of the disease, including potential targets for CRISPR-mediated therapies.
Dr. David B. Alexander
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- malignant gynecological diseases
- screening for gynecological cancers
- benign gynecological conditions
- screening for benign gynecological diseases
- endometriosis
- polycystic ovaries syndrome
- ovarian cysts
- uterine fibroids
- leiomyomas
- adenomyosis
- pelvic inflammatory disease
- vaginitis
- vaginal dysbiosis
- treatment targets for gynecological diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
